ClinicalTrials.Veeva

Menu

Robotic Therapy Hybridized With Mirror Therapy in Stroke Rehabilitation

National Taiwan University logo

National Taiwan University

Status

Invitation-only

Conditions

Stroke

Treatments

Other: Mirror therapy (MT)
Other: Dose-matched control intervention
Other: Robotic therapy (RT)

Study type

Interventional

Funder types

Other

Identifiers

NCT06777654
202410139RIND

Details and patient eligibility

About

The goal of this clinical trial is to compare the effects of three groups: (1) unilateral robotic therapy with computerized visual feedback plus unilateral innovative mirror therapy, (2) bilateral robotic therapy with computerized visual feedback plus bilateral innovative mirror therapy, and (3) dose-matched conventional rehabilitation as the control. The investigators will also study the factors predictive of treatment success, identify key predictors of clinical improvement, and distinguish patient profiles most likely to benefit from each regimen. The findings of this clinical trial are expected to advance knowledge about the synergistic effects of unilateral and bilateral hybrid programs. The predictive study of treatment outcomes will inform patient selection in precision rehabilitation toward personalized stroke management.

Enrollment

81 estimated patients

Sex

All

Ages

30 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

(1) a first ever-stroke≧3 months and less than 2 years, (2) age range between 30 to 80 years, (3) baseline Fugl-Meyer Assessment-Upper Extremity subscale (FMA-UE) between 18 to 56, (4) no excessive muscle spasticity of the affected extremities (Modified Ashworth Scale < 3 at any joints), (5) able to follow examiners' commands and study instructions (Montreal Cognitive Assessment score≧22), and (6) no fracture of upper extremities within the past 3 months, and (7) no participation in any other experimental rehabilitation or drug studies during study period of this project.

Exclusion criteria

(1) acute inflammation and pain, (2) receiving botulinum toxin injections within the past 3 months, and (3) concomitant neurologic, neuromuscular or orthopedic conditions that may interfere with participation in this research.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

81 participants in 3 patient groups

Unilateral RT plus unilateral innovative MT
Experimental group
Description:
Unilateral robotic therapy (RT) with computerized visual feedback plus unilateral innovative mirror therapy (MT)
Treatment:
Other: Robotic therapy (RT)
Other: Mirror therapy (MT)
Bilateral RT plus bilateral innovative MT
Experimental group
Description:
Bilateral robotic therapy (RT) with computerized visual feedback plus bilateral innovative mirror therapy (MT)
Treatment:
Other: Robotic therapy (RT)
Other: Mirror therapy (MT)
Dose-matched conventional rehabilitation
Active Comparator group
Description:
Dose-matched conventional rehabilitation as the control
Treatment:
Other: Dose-matched control intervention

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems